Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tier 1 and North | Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in northern region of China |
| |
| Tier 1 and South | Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in southern region of China |
| |
| Tier 2 and Middle | Site as described by tier level of the city where the site is located and by geographical location: Tier city in middle region of China |
| |
| Tier 2 and North | Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in northern region of China |
| |
| Tier 2 and South Eastern | Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south eastern region of China |
| |
| Tier 2 and South Western |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention | Other | No intervention administered in this study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Demographic and Socio-Behavioral Characteristics | At enrollment | |
| Medical History Characteristics | At enrollment | |
| Score Tumor Characteristics Based on Tumor Histology, Stage, Grade, and Lung Cancer Molecular Profile | At enrollment, during quarterly and semi-annual follow up and at end of study up to 1.5 years | |
| Grade of Eastern Cooperative Oncology Group (ECOG) Performance Status | At enrollment, during quarterly and semi-annual follow up and at end of study up to 1.5 years | |
| Treatment Patterns of First-Line and Subsequent Treatments | At enrollment, during quarterly and semi-annual follow up and at end of study up to 1.5 years | |
| Progression-Free Survival (PFS) | From enrollment to end of study up to 1.5 years | |
| Overall Survival (OS) | From enrollment to end of study up to 1.5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Score Health Economic Status Based on Household Income, Diagnosis and Treatment Costs, and Insurance Coverage | At enrollment, during quarterly and semi-annual follow up and at end of study up to 1.5 years | |
| Percentage of Serious Adverse Events (SAEs) | From enrollment to end of study up to 1.5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Participants with newly diagnosed, unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clinical Trials | Hoffmann-La Roche | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences. | Beijing | 100021 | China | |||
| the First Hospital of Jilin University |
Not provided
Not provided
Not provided
Not provided
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south western region of China |
|
| Percentage of Adverse Events (AEs) | From enrollment to end of study up to 1.5 years |
| Percentage of Non-Serious AEs of Special Interest (AESIs) | From enrollment to end of study up to 1.5 years |
| Changchun |
| 130021 |
| China |
| Sichuan Provincial Cancer Hospital | Chengdu | 610041 | China |
| Third Affiliated Hospital of Third Military Medical University | Chongqing | 400042 | China |
| Fujian Cancer Hospital | Fuzhou | 350014 | China |
| Harbin Medical University Cancer Hospital | Harbin | 150081 | China |
| The First Affiliate Hospital of Guangxi Medical University | Nanning | 530021 | China |
| Zhongshan Hospital Fudan University | Shanghai | 200032 | China |
| Shanghai First People's Hospital | Shanghai | 200080 | China |
| Union Hospital of Tongji Medical College, Dept. of Cancer Center; Cancer Center | Wuhan | 430023 | China |
| First Affiliated Hospital of Medical College of Xi'an Jiaotong University | Xi'an | 710061 | China |
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided